Astellas Pharma Inc. - Income Before Tax

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Income-Before-Tax" stands at 136.44 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2023.

Astellas Pharma Inc.'s second quarter result of 104.19 Billion JPY for the item "Income Before Tax" represents an increase of 15.23 percent compared to it's first quarter result.

Also, Astellas Pharma Inc.'s second quarter result of 104.19 Billion JPY for the item "Income Before Tax" represents an increase of 170.29 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of 136.44 Billion JPY for the item "Income Before Tax" represents an increase of 92.72 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 78.74 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 78.74 Billion Japanese Yens.
The 3 year change is -51.84 Billion Japanese Yens.
The 5 year change is -36.42 Billion Japanese Yens.
The 10 year change is -95.99 Billion Japanese Yens.

The Serie's long term average value is 166.15 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -29.71 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +214.42 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2016, to it's latest available value, on 09/30/2025, is -150.85 Billion.